Optical Bistability of Quantum Confined Modes in a Two-Dimensional Exciton–Polariton System
JETP Letters · 2026-02 · 123 (4) · 244-250
DOI: 10.1134/s0021364025610346 ↗Kurz gefasst
Fachartikel in der Zeitschrift JETP Letters, online erschienen am 30.03.2026. Verfasst von A. A. Demenev und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Exciton polaritons in a planar quantum well excited by a normally incident resonant light wave have been considered. Due to the nonlinearity caused by interparticle interactions, the optical response of a laterally homogeneous polariton system is bistable. It has been found that additional stability branches, characterized by different field distributions, can arise even in an effectively spinless system in the case where polariton motion in the quantum well plane is bounded by potential barriers. Fast and well controlled transitions between these branches are possible upon varying the frequency or amplitude of the incident wave. Such transitions have been experimentally demonstrated in a high- Q GaAs microcavity with a 60-μm square mesa.
Zitieren
APA
Demenev, A. A., Ipatov, N. N., Kulakovskii, V. D., & Gavrilov, S. S. (2026). Optical Bistability of Quantum Confined Modes in a Two-Dimensional Exciton–Polariton System. JETP Letters, 123(4), 244-250. https://doi.org/10.1134/s0021364025610346
Vancouver
Demenev AA, Ipatov NN, Kulakovskii VD, Gavrilov SS. Optical Bistability of Quantum Confined Modes in a Two-Dimensional Exciton–Polariton System. JETP Letters. 2026;123(4):244-250. doi:10.1134/s0021364025610346
BibTeX
@article{Demenev2026,
author = {Demenev, A. A. and Ipatov, N. N. and Kulakovskii, V. D. and Gavrilov, S. S.},
title = {Optical Bistability of Quantum Confined Modes in a Two-Dimensional Exciton–Polariton System},
journal = {JETP Letters},
year = {2026},
volume = {123},
number = {4},
pages = {244--250},
doi = {10.1134/s0021364025610346}
}
EUVIMED